NumFin

Nuo Therapeutics, Inc.

Symbol: AURX

PNK

0.8

USD

Markedspris i dag

  • -10.7721

    P/E-forhold

  • -0.1077

    PEG Ratio

  • 35.39M

    MRK Cap

  • 0.00%

    DIV Udbytte

Nuo Therapeutics, Inc. (AURX) Årsregnskaber

Download
ÅrligKvartalsvis
LineærLog
På diagrammet kan du se standardtallene i dynamik for Nuo Therapeutics, Inc. (AURX). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

ÅrligKvartalsvis
10Y20Y30Y40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Nuo Therapeutics, Inc., ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

balance-sheet.row.cash-and-short-term-investments

00.92.10.1
0.2
0.2
0.6
0.7
2.7
1
15.9
3.3
2.7
2.3
0.7
2.2
4
5.1
4.7
3.1
3.3
0.8
0.9
0.2
2.1
0.1

balance-sheet.row.short-term-investments

0000
0
0.2
0
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

00.30.10
0
0
0
0.1
0.7
1
1.9
3.9
1.7
1.5
1.2
0.2
0.5
0.7
1
0.4
0.3
0.2
0.2
0
0.2
0

balance-sheet.row.inventory

00.20.20
0
0
0
0
0.1
0.3
0.6
1.1
1.2
0.5
0.6
166731
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

00.20.20
0
0
0.2
0.3
0.3
0.8
2.3
0
0.1
0.8
1
0.2
0
0.1
0
0
0.3
0.2
0.3
0.3
0.1
0

balance-sheet.row.total-current-assets

01.62.60.1
0.2
0.2
0.9
1.2
3.8
3
21.9
10
6.4
5.2
3.5
2.5
4.7
6.1
5.8
3.8
3.9
1.2
1.4
0.5
2.5
0.2

balance-sheet.row.property-plant-equipment-net

00.30.40
0
0
0.1
0.2
0.5
1.1
0.9
0.9
2.4
1
1.3
0.1
0.1
0
0
0.1
0.2
0.2
0.3
0
0.5
0.1

balance-sheet.row.goodwill

0000
0
0
0
0
2.1
0
1.1
1.1
1.1
0.7
0.7
0
0
2
2
2
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
7.8
2.5
28.7
33.8
34.1
2.9
3.2
0
0
1.7
1.8
2
4.1
4.2
4.4
0.6
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
9.9
2.5
29.9
34.9
35.3
3.6
3.9
0
0
3.7
3.8
4
4.1
4.2
4.4
0.6
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0000
0
0
0
0
0.3
0.4
3.5
0.5
0.2
0.3
0.2
0
0
0.2
0.6
0
0
0
0
0.1
0.9
0

balance-sheet.row.total-non-current-assets

00.30.40
0
0
0.1
0.2
10.7
4
34.3
36.3
37.9
4.9
5.4
0.1
0.1
3.9
4.4
4.1
4.3
4.5
4.7
0.7
1.4
0.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01.930.1
0.2
0.2
1
1.4
14.5
7.1
56.2
46.3
44.3
10.1
8.9
2.6
4.8
10
10.2
7.9
8.2
5.7
6.2
1.2
3.9
0.3

balance-sheet.row.account-payables

00.40.40.5
0.5
0.5
0.4
0.4
0.4
1.1
1.9
3.4
1.4
1.2
3.6
1
1.3
0.1
1.2
1.1
1
0.6
0.7
0.1
0.8
0.1

balance-sheet.row.short-term-debt

00.10.10
0
0.7
0.3
0
-0.1
35
2.5
1.8
0
0
1.5
0
0
0.8
0
0
0
0
0
0.2
0
0.2

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

00.20.30
0
0
0
0
0
0
0.3
3.8
2.1
2.1
2
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0.6
1
1.4
-0.7
0
0
0
0
197344
191475
263745
0
0
0
0.6
0
0.1

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

00.30.10.1
0.1
0.1
0.3
0.5
1
5
3.7
2.9
1.4
1.3
0.1
0
0
0
0
0
0.2
0.1
0
0.1
-0.1
0

balance-sheet.row.total-non-current-liabilities

00.20.30
0
0
0.7
0
0.2
1.4
31.8
9.4
3.5
3.7
3.8
1
0.1
0.2
0.4
0.3
0.4
0.4
0.6
10
1.8
1.7

balance-sheet.row.other-liabilities

0000
0
0
-0.7
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

00.20.30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

00.80.90.7
0.7
0.7
1.1
0.9
1.6
43.6
40.3
19.9
6.3
6.8
9
1
1.7
1.4
1.7
1.5
1.7
1.3
1.5
10.8
2.9
2.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0.9
0.4
0.5
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-29.9-26.8-23.5
-23.5
-23.5
-22.2
-20.7
-5.2
-162.9
-110.1
-91.2
-71
-51.2
-47.7
-42.5
-39.1
-31.4
-26.6
-24.3
-17.7
-6.5
-2.1
-60.8
-39.6
-6.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
-0.1
0
0
0
0
0
0
0
0
0
-0.6
-0.2
-1.4
-1.4
-0.2
0
0
0

balance-sheet.row.other-total-stockholders-equity

0312923
23
23
22.1
21.2
18.2
126.3
125.2
117.1
108.5
54.5
47.6
44.1
42.2
40
35.8
31
25.7
12.4
6.9
51.3
40.6
4.4

balance-sheet.row.total-stockholders-equity

012.2-0.5
-0.5
-0.5
-0.1
0.5
12.9
-36.6
16
26.3
38
3.3
-0.1
1.5
3.1
8.6
8.5
6.4
6.5
4.5
4.7
-9.6
1
-1.8

balance-sheet.row.total-liabilities-and-stockholders-equity

01.930.1
0.2
0.2
1
1.4
14.5
7.1
56.2
46.3
44.3
10.1
8.9
2.6
4.8
10
10.2
7.9
8.2
5.7
6.2
1.2
3.9
0.3

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

012.2-0.5
-0.5
-0.5
-0.1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
0.2
0
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

00.30.30
0
0.7
0.3
0
0
35
0.3
5.6
2.1
2.1
3.5
0
0
0
0
0
0
0
0
0.2
0
0.2

balance-sheet.row.net-debt

0-0.7-1.7-0.1
-0.2
0.5
-0.3
-0.7
-2.7
34.1
-15.6
2.3
-0.5
-0.1
2.9
-2.1
-4
-5.1
-4.7
-3.1
-3.3
-0.8
-0.9
0
-2.1
0.1

Pengestrømsopgørelse

Det økonomiske landskab for Nuo Therapeutics, Inc. har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

0-3.2-3.20
0
0
-1.5
-15
0
-52.8
-18.9
-20.2
-19.8
-3.5
-6.8
-3.4
-7.7
-5
-2.3
-6.5
-8.1
-4.1
-2
-21.2
-33.3
-6.2

cash-flows.row.depreciation-and-amortization

00.10.10
0
0.1
0.1
1.1
0
0.7
0.6
1.1
1.2
0.6
0.4
0
0.2
0.2
0.2
2.2
3.3
1.2
0.1
0.5
0.1
0

cash-flows.row.deferred-income-tax

0000
0
-0.4
-0.2
0
0
-0.1
0
0
0
0
0
-0.4
3.5
-1014966
-129794
-1526088
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00013936
0.3
0.1
0
0.1
0
0.8
1.3
0.7
2
0.3
0.4
0.4
0.7
1014966
129794
1526088
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-0.3-0.50
0
0
0.7
-0.3
0
0.2
0.8
5.2
-1.5
-1.3
1.6
-0.3
0.8
0.4
-0.8
-0.1
0.1
0.1
-0.6
0.5
0.4
0.1

cash-flows.row.account-receivables

0-0.3-0.10
0
0
0.3
277.1
0
695612
2005581
-2268104
-260510
-0.9
-1
0.3
0.2
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

00-0.20
0
0
0
0
0
0.3
0.5
0.1
-0.6
0.1
0.5
287430.7
-377027.4
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0000
0
0
0.1
0
0
-0.8
-1.5
5206301
-83767
-1055983
2356062
-287431
377028
-190818
98217
94678
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-0.20
0
0
0.4
-277.4
0
-695611.2
-2005579.2
-2938191.9
344276.1
1055982.5
-2356059.9
-0.3
-0.1
190818.4
-98217.8
-94678.1
0.1
0.1
-0.6
0.5
0.4
0

cash-flows.row.other-non-cash-items

00.2-0.1-13936
-0.3
-0.1
0
9.2
0
36.7
-1.2
1.9
6.7
-0.3
0.8
0.4
0
2.3
1.2
0.2
0
0.1
0.5
17.4
28.3
5.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-0.10
0
0
0
0
0
-0.7
-0.5
-0.8
-2.1
-0.1
-0.8
0
-0.1
0
0
0
-0.1
0
-0.3
0
-0.6
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
-2
0
0
0
0
0
0
0
0
-2.4
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
-0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0
0.1
0
0.1
0.1
2.1
0.5
0.1
0.1
0
0
0
0
0.1
0
0
0
0.2
-0.8
0.4

cash-flows.row.net-cash-used-for-investing-activites

00-0.10
0
0
0
0.1
0
-0.6
-0.3
1.4
-1.6
0
-2.7
-0.1
-0.1
0
0
0.1
-0.1
0
-0.3
-2.3
-1.4
0.4

cash-flows.row.debt-repayment

0000
0
0
0
0
0
0
-6.2
-1
-9.5
-2.6
-0.5
0
0
0
-11035
0
0
0
0
0
-0.2
-0.2

cash-flows.row.common-stock-issued

024.51.4
0.2
0
0.5
2.9
0
0
3.7
5.5
9.5
3.8
1.9
1.4
1.4
2.6
3.2
4
7.2
2.7
3.2
0
8
0.4

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
-0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11035
-0.1
0
0
0
0
0
0

cash-flows.row.other-financing-activites

024.51373092
0.2
0.3
0.3
0
0
0
33
6.2
13.6
4.7
3.4
0
0
0
22070
0
0
-0.1
-0.1
3.2
0
0.2

cash-flows.row.net-cash-used-provided-by-financing-activities

024.51373092
0.2
0.3
0.8
2.9
0
0
30.4
10.7
13.4
5.8
4.8
1.4
1.4
2.6
3.2
3.9
7.2
2.6
3.1
3.2
7.8
0.4

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-1.20.70
0
0
-0.1
-1.9
0
-15
12.7
0.7
0.4
1.6
-1.5
-1.9
-1.1
0.5
1.5
-0.2
2.5
-0.1
0.9
-1.9
2
0.1

cash-flows.row.cash-at-end-of-period

00.92.10.1
0.2
0.2
0.6
0.7
0
0.9
15.9
3.3
2.6
2.2
0.6
2.1
4
5.1
4.7
3.1
3.3
0.8
1
0.2
2.1
0.1

cash-flows.row.cash-at-beginning-of-period

02.11.40.2
0.2
0.2
0.7
2.6
0
15.9
3.3
2.6
2.2
0.6
2.1
4
5.1
4.7
3.1
3.3
0.8
0.9
0.1
2.1
0.1
0

cash-flows.row.operating-cash-flow

0-3.2-3.70
0
0
-0.9
-4.9
0
-14.4
-17.4
-11.4
-11.4
-4.2
-3.5
-3.2
-2.5
-2.1
-1.7
-4.2
-4.7
-2.7
-1.9
-2.8
-4.4
-0.7

cash-flows.row.capital-expenditure

00-0.10
0
0
0
0
0
-0.7
-0.5
-0.8
-2.1
-0.1
-0.8
0
-0.1
0
0
0
-0.1
0
-0.3
0
-0.6
0

cash-flows.row.free-cash-flow

0-3.2-3.80
0
0
-0.9
-4.9
0
-15.1
-17.9
-12.2
-13.5
-4.3
-4.3
-3.3
-2.6
-2.2
-1.7
-4.2
-4.8
-2.7
-2.2
-2.9
-5
-0.7

Resultatopgørelse række

Nuo Therapeutics, Inc.s omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for AURX rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

income-statement-row.row.total-revenue

00.60.10
0
0.1
1.4
0.7
2205
11.5
7.8
11.6
10.6
7.2
3.9
2.1
2.1
1.9
1.9
1.5
1.1
1.1
0.4
0
0.3
0

income-statement-row.row.cost-of-revenue

00.100
0
0.1
0.2
1.1
1613
8
6.8
8.5
3.9
2.7
1.6
0.5
0.6
0.9
1
0.9
0.7
0.8
0.1
0
0.1
0

income-statement-row.row.gross-profit

00.50.10
0
0
1.2
-0.4
592
3.5
1
3.1
6.6
4.5
2.3
1.6
1.5
1.1
0.9
0.6
0.4
0.3
0.3
0
0.3
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0
0.6
0
0
0
0
-2
1473670
1930655
2187696
6018366
1028137
1528361
4706508
0
0
0.4
3.7
31.9
3.2

income-statement-row.row.operating-expenses

03.73.40.1
0.4
1
2.7
5.9
0
17.8
19.7
21.2
19.5
8
7.7
5.1
5.8
6.4
5.1
8.1
8.6
4.5
2.4
5.5
33.7
3.5

income-statement-row.row.cost-and-expenses

03.83.40.1
0.4
1.1
2.9
7
1613
25.8
26.5
29.7
23.5
10.8
9.3
5.5
6.4
7.3
6.1
9
9.3
5.2
2.4
5.5
33.8
3.5

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.2
0.1
0.1
0
0
0
0.2
0

income-statement-row.row.interest-expense

000-48390
0
0.2
0
0
0
3.8
3.4
1.7
1
1
-0.8
0
0.2
-0.3
-1.9
-6.5
0
0
0
5.6
0
-6.2

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

000.1287189
0.3
-0.2
0
-8.7
0
-34.9
3.3
-0.5
-5.8
1.1
-0.6
0
-3.5
0
1.7
0.8
0
0
-0.3
11.1
-0.4
-2.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0
0.6
0
0
0
0
-2
1473670
1930655
2187696
6018366
1028137
1528361
4706508
0
0
0.4
3.7
31.9
3.2

income-statement-row.row.total-operating-expenses

000.1287189
0.3
-0.2
0
-8.7
0
-34.9
3.3
-0.5
-5.8
1.1
-0.6
0
-3.5
0
1.7
0.8
0
0
-0.3
11.1
-0.4
-2.7

income-statement-row.row.interest-expense

000-48390
0
0.2
0
0
0
3.8
3.4
1.7
1
1
-0.8
0
0.2
-0.3
-1.9
-6.5
0
0
0
5.6
0
-6.2

income-statement-row.row.depreciation-and-amortization

00.10.10.1
0.1
0
0.1
1.1
0
0.7
0.6
1.1
1.2
0.6
0.4
0
0.2
0.2
0.2
2.2
3.3
1.2
0.1
0.5
0.1
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-3.2-3.3-0.1
-0.4
-1
-1.5
-15.5
592
-41.3
-23.4
-18.1
-12.9
-3.5
-5.4
-3.4
-7.9
-5.4
-4.2
-7.4
-8.2
-4.1
-2
-5.4
-33.5
-6.2

income-statement-row.row.income-before-tax

0-3.2-3.2-0.1
-0.1
-1.2
-1.5
-15
0
-52.9
-18.9
-20.2
-19.8
-3.5
-6.8
-3.4
-7.7
-5
-2.3
-6.5
-8.1
-4.1
-2
-21.2
-33.3
-6.2

income-statement-row.row.income-tax-expense

00-0.1287188.9
0
0.2
0
-0.6
0
-0.1
0
0
0
0
0
0
-0.2
-0.3
-1.9
6.5
8.1
4.1
2
21.2
33.3
6.2

income-statement-row.row.net-income

0-3.2-3-0.1
-0.1
-1.4
-1.5
-15
0
-52.8
-18.9
-20.2
-19.8
-3.5
-6.8
-3.4
-7.7
-5
-2.3
-6.5
-8.1
-4.1
-2
-21.2
-33.3
-6.2
Lignende aktier
Du er måske også interesseret i:
MRVI
Maravai LifeSciences Holdings, Inc..
9.86 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.02684 USD
NASDAQ
GUBRA.CO
Gubra A/S.
338 DKK
CPH
T5O.DE
CytoTools AG.
0.406 EUR
XETRA
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0774 USD
PNK

Ofte stillede spørgsmål

Hvad er Nuo Therapeutics, Inc. (AURX) samlede aktiver?

Nuo Therapeutics, Inc. (AURX) samlede aktiver er 1877880.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er N/A.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.793.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er -0.074.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er -5.214.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er -5.206.

Hvad er Nuo Therapeutics, Inc. (AURX) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er -3171436.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 255592.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 3650707.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 0.000.